Get the app
US › Healthcare

China SXT Pharmaceuticals Inc (SXTC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.83-3.41%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$1.2M
Revenue YoY
+163.0%
Net profit
$163,718
Net margin
13.7%

Key statistics

Market cap
$298,296
Forward P/E
0.0
P/B
0.01
Book value
$2,480.58
EPS (TTM)
$-75,667.34
52-week high
$1,000,000.00
52-week low
$2.71
50-day MA
$167.50
200-day MA
$14,902.71
Beta
2.01

Shareholding

Insiders
2.26%

Largest institutional holders

FundStake
Royal Bank of Canada0.00%
Caitong International Asset Management Co., Limited.0.00%
UBS Group AG0.00%
Sabby Management LLC0.00%

Corporate actions

ActionDetailDate
Split1 : 100
effective Oct 26, 2026		2026-10-26

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for China SXT Pharmaceuticals Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.